D. Readett

发表

Lack of Effect of Rivipansel on QTc Interval in Healthy Adult African American Male Subjects

J. Korth-Bradley, A. Płotka, B. Tammara, 2017, Journal of clinical pharmacology.

Effect of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intravenous Rivipansel

J. Korth-Bradley, A. Płotka, B. Tammara, 2020, Clinical pharmacology in drug development.

The Mount Isa Mines limited copper solvent extraction and electrowinning plant

G. R. M. Miller, D. J. Readett, G. Miller, 1992 .

A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer.

M. Krzakowski, J. Jassem, E. Tan, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer.

C. Leichman, A. Krieg, V. Hirsh, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The surface chemistry of low-rank coals

K. Quast, D. Readett, 1987 .

Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer.

L. Paz-Ares, A. Szczesna, J. Schiller, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Polytherapie associant un anticorps anti-ctla-4 et un oligodesoxynucleotide synthetique a motif cpg destinee au traitement du cancer

J. Gómez-Navarro, A. Krieg, J. U. Jungnelius, 2006 .

A Randomized Clinical Trial of the Efficacy and Safety of Rivipansel for Sickle Cell Vaso-occlusive Crisis (VOC).

M. Telen, T. Wun, J. Lozier, 2022, Blood.

Annals of Oncology

M. Krzakowski, J. Jassem, E. Tan, 2022 .

Experience in operating the girilambone copper SX-EW plant in changing chemical environments

G. Miller, P. Hutchinson, D. Readett, 1997 .

Phase I dose escalation trial of tremelimumab (CP-675,206) administered in combination with PF-3512676 in patients with melanoma or other advanced cancers.

M. Millward, J. Gómez-Navarro, C. Bulanhagui, 2016, Journal of Clinical Oncology.

Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 as first line treatment of advanced non-small cell lung cancer (NSCLC)

J. Schiller, R. Rosell, R. Benner, 2008 .

Early Initiation of Treatment with Rivipansel for Acute Vaso-Occlusive Crisis in Sickle Cell Disease (SCD) Achieves Earlier Discontinuation of IV Opioids and Shorter Hospital Stay: Reset Clinical Trial Analysis

M. Telen, Wally R. Smith, T. Wun, 2020 .